Overview
Takafumi Akagami practices practicing medicine in Nishinomiya-hama, Japan.
Their clinical expertise encompasses Familial Transthyretin Amyloidosis and Type 1 Diabetes (T1D).
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Takafumi Akagami
Is Takafumi Akagami a top-rated expert for Familial Transthyretin Amyloidosis?
MediFind is an objective health platform that identifies experts based on real-world data. Takafumi Akagami is classified as an Experienced expert for Familial Transthyretin Amyloidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Takafumi Akagami participate in research or clinical trials?
Yes. Takafumi Akagami has published 9 articles and abstracts on conditions like Familial Transthyretin Amyloidosis. You can view a list of Takafumi Akagami's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Familial Transthyretin Amyloidosis
- Type 1 Diabetes (T1D)Akagami isExperienced. Learn about Type 1 Diabetes (T1D).